“Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel)”. 2023. Clinical Oncohematology. Basic Research and Clinical Practice 16 (2): 227-28. https://doi.org/10.21320/2500-2139-2023-16-2-resolution.